receptor antagonists for the alleviation of cognitive deficits of down syndrome

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9029379
APP PUB NO 20130210829A1
SERIAL NO

13837887

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for treating Down syndrome and improving cognitive function of a patient with an intellectual disability are disclosed. 5-hydroxytryptamine sub-receptor six (5-HT6) receptor antagonists are provided for improving the cognition of a Down syndrome patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • UNIVERSITY OF UTAH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kesner, Raymond Pierre Salt Lake City, US 4 10
Korenberg, Julie Ruth Los Angeles, US 4 10
West, Peter Jeffrey Bountiful, US 4 10
Wilcox, Karen Sue Sandy, US 4 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 12, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00